UICC, pfizer issue grants totaling US$500,000 to 20 organisations to address cancer patient needs

The Union for International Cancer Control (UICC ) is the largest international cancer-fighting organisation, with over 1,000 member organisations across 164 countries representing the world’s major cancer societies, ministries of health, research institutes, treatment centres and patient groups, according to NigeriaToday.ng.

The organisation is dedicated to taking the lead in convening, capacity building and advocacy initiatives that unite the cancer community to reduce the global cancer burden, promote greater equity, and integrate cancer control into the world health and development agenda.

UICC recently, in partnership with Pfizer Oncology revealed organisations involved in the second phase of the Seeding Progress and Resources for the Cancer Community: Metastatic Breast Cancer Challenge (SPARC MBC Challenge).

Metastatic breast cancer is the most advanced stage of breast cancer and occurs when cancer spreads beyond the breast to other parts of the body, including the bones, lungs, liver and brain.

Two beneficiaries from Nigeria include University of Ibadan, Run for a Cure Africa Breast Cancer Foundation, Ikoyi, Nigeria. Others include: Fundación Cáncer-Fuca, Buenos Aires, Argentina, Europa Donna Cyprus, Nicosia, Cyprus, The Aga Khan University (Nairobi), Nairobi, Kenya, St. Leonards, Australia, Caribbean Cancer Research Initiative, San Fernando, Trinidad and Tobago, Cancer Patients Aid Association, Mumbai, India, Societatea Romana de Cancer (Romanian Cancer Society), Cluj Napoca, Romania, Hellenic Association of Women with Breast Cancer “Alma Zois”, Athens, Greece, Clinique medical Camassistance, Yaounde, Cameroon to mention a few.

The 20 organisations from 19 countries that have been selected will receive grants amounting to US$500,000 in funding provided by Pfizer to execute developments tackling the exact requests of women with metastatic breast cancer worldwide.

When the call was made for the application, 83 submissions from organisations in 42 countries were received and awardees were chosen through a rigorous process.

According to UICC President, Sanchia Aranda, a Professor, “There is an urgent need for greater access to comprehensive breast cancer services and support for women living with metastatic breast cancer, particularly in low- and middle-income countries where the majority of breast cancer cases are diagnosed at advanced stages of the disease. We are glad to support cancer organisations across the globe in initiating and developing projects that will have a real impact in their own settings.” Sanchia said.

Furthermore, Pfizer Oncology is providing another US$30,000 to support the continuation of selected ongoing SPARC projects from the first round of grants issued in 2015. This brings Pfizer’s total funding of the initiative to more than US$1.3 Million.


Read more HERE



Leave a Reply

Your email address will not be published. Required fields are marked *

3 + 20 =